ALC Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03
Harga $63.76
P/E (TTM) 8.8
EPS (TTM) $7.28
Pendapatan (TTM) $7.18B
ROE 4.5%
Rentang 52M $62–$88

ALC Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04
rentang
batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Tentang Alcon Inc. Ordinary Shares Tinjauan perusahaan dari Wikipedia

05 · wikidata

Alcon, (NYSE: ACL) adalah sebuah perusahaan yang bergerak di industri medis, dengan spesialisasi di bidang perawatan kesehatan mata. Markas besar perusahaan ini terletak di Fort Worth, Texas, Amerika Serikat.

Sejarah

Alcon didirikan pada tahun 1945 di Amerika Serikat. Perusahaan ini awalnya merupakan sebuah perusahaan farmasi kecil yang diberi nama berdasarkan nama pendirinya, Robert Alexander dan William Conner. Conner dan Alexander pada produk ophthalmis steril. Perusahaan ini diresmikan menjadi sebuah perusahaan publik tahun 1947.

Pada tahun 1977, Nestlé dari Swiss membeli Alcon. Alcon kemudian mengembangkan pasar dan mendirikan pabrik-pabrik baru di Amerika Selatan serta Eropa, selain itu, biaya untuk riset dan pengembangan juga ditingkatkan. Pada tahun 80 dan 90-an, Alcon menjadi perusahaan ophthalmis terbesar di dunia. Produk-produk Alcon juga mulai memproduksi peralatan operasi. Saat ini, Alcon beroperasi di 75 negara dan produknya dijual di lebih dari 180 negara. Alcon mempekerjakan sekitar 12.000 pekerja di seluruh dunia.

Alcon berpisah dari Nestlé tahun 2002 dan didaftarkan kembali ke NYSE dan mengeluarkan IPO pada tanggal 21 Maret. Namun demikian, Nestlé tetap menjadi pemegang saham terbesar di Alcon.

Pada 7 April 2008, Novartis mengumumkan akan membeli saham yang dimiliki oleh Nestlé dengan nilai lebih dari USD39 miliar.

Produk konsumen

Perawatan lensa kontak

Opti-Free RepleniSH Multi-Purpose Disinfecting Solution

Opti-Free Express No Rub Solution

Opti-Free Supraclens Active Cleaner

Unique-pH Multi-Purpose Solution (discontinued production on July 2007)

Clerz Plus Lens Drops

PLIAGEL Cleaning Solution

ALCON Saline Solution

UNISOL 4 Saline Solution

Obat tetes mata

Systane Lubricant Eye Drops

Tears Naturale Forte Lubricant Eye Drops

Tears Naturale Lubricant Eye Drops

Tears Naturale II Lubricant Eye Drops

Bion Tears Lubricant Eye Drops

Poly-Tears Lubricating Eye Drops

Produk lain

ICAPS Vitamins

Naphcon-A Eye Allergy Drops

Produk farmakologi

Glukoma

Azopt (brinzolamida)

Betoptic (betaksolol)

Betoptic S (suspensi betaksolol)

DuoTrav (travoprost/timolol)

Iopidine (apraklonidin)

Isopto Carbachol (karbakol)

Isopto Carpine (pilokarpin)

Travatan (travoprost)

Travatan Z (travoprost)

Antibiotik ocular

Ciloxan (siprofloksasin)

TobraDex (tobramisin/deksametason)

Tobrex (tobramisin)

Vigamox (moksifloksasin)

Ocular Allergy Agents

Pataday (olopatadin)

Patanol (olopatadin)

Ocular anti-inflammatory agents

Flucon/Flarex (Fluorometolon)

Maxidex (deksametason)

Nevanac (nepafenak)

Vexol (rimeksolon)

Otic antibiotics

Ciproxin HC/Cipro HC (siprofloksasin/hidrokortison)

Ciprodex Otic (siprofloksasin/deksametason)

Econopred Plus (prednisolon asetat)

Macular degeneration

Retaane (anecortave)

Produk operasi

LADARVision (untuk laser eye surgery)

LADAR-6000 surgical laser

INFINITI; Vision System Diarsipkan 2008-05-11 di Wayback Machine. (untuk operasi phacoemulsification cataract)

Peralatan Ophthalmic Viscosurgical

Acrysof Iolstm

Provisctm

Viscoattm

Duovisc (kombinasi Provisctm & Viscoattm)

Discovisctm

Celoftaltm

Celoftal Plustm

Cellugeltm

Referensi

Pranala luar

Situs web resmi

Sumber: Wikipedia, CC BY-SA 4.0 · Lihat di Wikipedia ↗

Wikidata ↗

sektorHealth Care industriHealth Care karyawan25.000 negaraCH

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06
Pendapatan$10.40B
2010-12-31 → 2025-12-31
EPS$1.98
2010-12-31 → 2025-12-31
Arus Kas Bebas$1.73B
2019-12-31 → 2025-12-31
Margin bersih30.8%
2019-12-31 → 2025-12-31
Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik Tren 5 Tahun ALC rata-rata 5T Median Rekan Kesimpulan
P/E (TTM) 8.8rata-rata 5T ≈67.3 ≈67.3 · ·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun

13
Rasio Pembayaran Dividen16.9%
Pembayaran Tahunan≈$0.36Dibayar tahunan
Rentetan Pertumbuhan≈3Tahun berturut-turut pertumbuhan dividen
Tanggal ex-dividenJumlahMata UangImbal Hasil
Mei 5, 2026$0,36USD≈0.48%
Mei 13, 2025$0,33USD≈0.35%
Mei 14, 2024$0,26USD≈0.30%
Mei 10, 2023$0,24USD≈0.29%
Mei 3, 2022$0,21USD≈0.29%
Mei 4, 2021$0,11USD≈0.15%

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14
Kejutan Rata-rata 3.0%
PeriodeLaporanEPS AktualEPS EstimasiKejutan
30 Juni 2026 $0.84 $0.76 10.5%
31 Maret 2026 $0.85 $0.82 3.4%
31 Des. 2025 $0.78 $0.79 -1.6%
30 Sep. 2025 $0.79 $0.77 2.9%
30 Juni 2025 $0.76 $0.73 4.5%
31 Maret 2025 $0.78 $0.79 -1.6%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15
Laporan Laba Rugi 17
Metrik Tren 202520242023202220212020201920182010200920082007
Revenue $10.40B$9.91B$9.46B$8.72B$8.29B$6.83B$7.51B$7.15B$7.18B$6.50B$6.29B$5.60B
Cost of Revenue $4.59B$4.33B$4.14B$3.91B$3.58B$3.83B$3.72B$3.96B$1.68B$1.61B$1.47B$1.40B
Gross Profit $5.75B$5.51B$5.25B$4.75B$4.65B$2.94B$3.66B$3.19B$5.50B$4.88B$4.82B$4.20B
R&D Expense $990M$876M$828M$702M$842M$673M$656M$587M$747M$665M$619M$564M
SG&A Expense $3.45B$3.25B$3.21B$3.07B$3.08B$2.69B$2.85B$2.80B····
Operating Income $1.36B$1.41B$1.04B$672M$580M$-482M$-187M$-248M$2.48B$2.26B$2.21B$1.88B
Interest Expense $204M$192M$189M$134M$120M$124M$113M$24M$9M$16M$51M$50M
Interest Income $74M$84M$45M$16M$3M$6M$8M$2M····
Other Non-op ········$35M$25M$-134M$16M
Pretax Income $1.16B$1.26B$832M$463M$418M$-635M$-332M$-300M$2.53B$2.31B$2.08B$1.93B
Income Tax $180M$238M$-142M$128M$42M$-104M$324M$-73M$317M$306M$36M$343M
Net Income $980M$1.02B$974M$335M$376M$-531M$-656M$-227M$2.21B$2.01B$2.05B$1.59B
EPS (Basic) $1.99$2.06$1.98$0.68$0.77$-1.09$-1.34$-0.46$7.34$6.72$6.86$5.32
EPS (Diluted) $1.98$2.05$1.96$0.68$0.76$-1.09$-1.34$-0.46$7.27$6.66$6.79$5.25
Shares (Basic) 493,200,000494,400,000493,000,000491,400,000490,000,000489,000,000488,200,000488,200,000300,932,749298,847,072298,504,732·
Shares (Diluted) 496,200,000497,500,000496,500,000494,400,000493,400,000489,000,000488,200,000488,200,000304,104,272301,348,181301,582,676302,162,019,000,000
EBITDA $1.36B$1.41B$1.04B$672M$580M$-482M$-187M·····
Neraca 28
Metrik Tren 202520242023202220212020201920182010200920082007
Cash & Equivalents $1.53B$1.68B$1.09B$980M$1.57B$1.56B$822M$227M$2.52B$3.01B$2.45B$2.13B
Short-term Investments ········$889M$479M$564M·
Receivables ········$1.48B$1.35B$1.17B·
Inventory $2.39B$2.27B$2.32B$2.11B$1.90B$1.64B$1.50B$1.44B$693M$626M$574M·
Other Current Assets ········$307M$213M$243M·
Current Assets $6.45B$6.31B$5.65B$5.19B$5.39B$4.99B$4.24B$3.40B$6.07B$5.83B$5.22B·
PP&E (Net) $4.77B$4.39B$4.37B$4.03B$3.71B$3.42B$3.11B$2.80B$1.39B$1.30B$1.14B·
PP&E (Gross) ········$2.87B$2.65B··
Accum. Depreciation ········$1.48B$1.35B··
Goodwill $9.26B$8.95B$8.93B$8.93B$8.90B$8.90B$8.90B$8.90B$833M$688M$645M·
Intangibles $9.01B$8.59B$9.06B$9.69B$8.77B$9.10B$10.23B$10.68B$953M$255M$91M·
Other Non-current Assets ········$171M$142M$92M·
Total Assets $31.55B$30.35B$29.61B$29.16B$28.00B$27.60B$27.66B$27.06B$10.07B$8.69B$7.55B·
Accounts Payable ········$370M$321M$199M·
Short-term Debt ········$337M$607M$1.06B·
Current Liabilities $3.05B$2.28B$2.40B$2.74B$2.47B$2.26B$2.30B$1.89B$1.79B$1.98B$2.19B·
Deferred Tax ········$65M$59M$22M·
Other Non-current Liabilities ········$965M$691M$587M·
Total Liabilities $9.52B$8.79B$8.99B$9.49B$8.74B$8.78B$8.35B$4.42B····
Long-term Debt ········$62M$56M$62M·
Common Stock ········$42M$42M$42M·
Paid-in Capital ········$1.67B$1.53B$1.45B·
Retained Earnings ········$5.71B$4.53B$3.70B·
Treasury Stock ········$263M$408M$579M·
AOCI ········$98M$203M$80M·
Stockholders' Equity $22.03B$21.55B$20.62B$19.68B$19.26B$18.82B$19.30B$22.64B$7.25B$5.91B$4.69B$3.38B
Liabilities + Equity ········$10.07B$8.69B$7.55B·
Shares Outstanding ········302,390,266299,550,733298,648,353297,662,706
Arus Kas 14
Metrik Tren 202520242023202220212020201920182010200920082007
Stock-based Comp ·········$74M$83M$84M
Deferred Tax ········$4M$51M$-146M$-26M
Amort. of Intangibles ········$60M$24M$29M$51M
Operating Cash Flow $2.27B$2.08B$1.39B$1.22B$1.34B$823M$920M$1.14B$2.38B$2.42B$2.03B$1.47B
CapEx $543M$473M$658M$636M$700M$479M$553M$524M$309M$342M$302M$227M
Investing Cash Flow $-1.34B$-1.17B$-1.09B$-1.86B$-1.20B$-572M$-1.01B$-1.00B$-1.71B$-390M$-365M$-227M
Debt Issued ·········$0$0$1M
Stock Repurchased ········$33M$7M$127M$1.00B
Dividends Paid $166M$130M$116M$100M$54M$0$0·$1.04B$1.05B$749M$613M
Financing Cash Flow $-1.12B$-322M$-211M$-8M$-123M$466M$659M$-78M$-1.15B$-1.48B$-1.33B$-607M
Net Change in Cash ········$-482M$558M$315M$645M
Taxes Paid ········$284M$262M$232M·
Free Cash Flow $1.73B$1.60B$730M$581M$645M$344M$367M·····
Levered FCF $1.56B$1.45B$509M$484M$537M$240M$144M·····
Profitabilitas 8
Metrik Tren 202520242023202220212020201920182010200920082007
Gross Margin 55.2%55.6%55.5%54.5%56.1%43.0%48.8%·····
Operating Margin 13.1%14.3%11.0%7.7%7.0%-7.0%-2.5%·····
Net Margin 9.4%10.3%10.3%3.8%4.5%-7.8%-8.7%·····
Pretax Margin 11.2%12.7%8.8%5.3%5.0%-9.3%-4.4%·····
EBITDA Margin 13.1%14.3%11.0%7.7%7.0%-7.0%-2.5%·····
ROA 3.2%3.4%3.3%1.2%1.4%-1.9%-2.4%·····
ROE 4.5%4.8%4.8%1.7%2.0%-2.8%-3.1%·····
ROIC 5.2%5.3%5.9%2.5%2.7%-2.1%-1.9%·····
Likuiditas & Solvabilitas 3
Metrik Tren 202520242023202220212020201920182010200920082007
Current Ratio 2.12.82.31.92.22.21.8·····
Quick Ratio 0.50.70.40.40.60.70.4·····
Interest Coverage 6.77.45.55.04.8-3.9-1.7·····
Efisiensi 2
Metrik Tren 202520242023202220212020201920182010200920082007
Asset Turnover 0.30.30.30.30.30.20.3·····
Inventory Turnover 2.01.91.92.02.02.42.5·····
Per Saham 3
Metrik Tren 202520242023202220212020201920182010200920082007
Revenue / Share $20.96$19.92$19.04$17.63$16.80$13.97$15.38·····
Cash Flow / Share $4.58$4.17$2.80$2.46$2.73$1.68$1.88·····
EPS (TTM) $1.98$2.05$1.96$0.68$0.76$-1.09$-1.34·····
Valuasi (TTM) 6
Metrik Tren 202520242023202220212020201920182010200920082007
Revenue TTM $10.40B$9.91B$9.46B$8.72B$8.29B$6.83B$7.51B·····
Net Income TTM $980M$1.02B$974M$335M$376M$-531M$-656M·····
P/E 39.841.439.9100.8114.6-60.5-42.2·····
Earnings Yield 2.5%2.4%2.5%0.99%0.87%-1.7%-2.4%·····
Payout Ratio 16.9%12.8%11.9%29.8%14.4%·······
Annual Payout $166M$130M$116M$100M$54M$0$0·····

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16
Metrik 2025-12-312024-12-312023-12-312022-12-312021-12-31
Pendapatan $10.40B $9.91B $9.46B $8.72B $8.29B
Margin Kotor % 55.2% 55.6% 55.5% 54.5% 56.1%
Margin Operasi % 13.1% 14.3% 11.0% 7.7% 7.0%
Laba Bersih $980M $1.02B $974M $335M $376M
EPS Dilusian $1.98 $2.05 $1.96 $0.68 $0.76

Pemilik institusional (13F) 705 pengaju · $18.3B total · Per tanggal 30 Sep. 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 705
Nilai yang dipegang $18.3B
Posisi baru 79
Posisi yang keluar 86
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
Posisi baru Posisi yang keluar Meningkat Menurun Perubahan bersih saham
79 (-18 vs Kuartal sebelumnya) 86 (+17 vs Kuartal sebelumnya) 159 (-34 vs Kuartal sebelumnya) 281 (+28 vs Kuartal sebelumnya) +19.8M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi Nilai Saham % dari 13F yang dilacak Tipe
VANGUARD GROUP INC $1.698.441.362 21.464.480 9,28% Saham
VANGUARD CAPITAL MANAGEMENT LLC $994.564.314 14.749.582 5,43% Saham
Bank of New York Mellon Corp $876.189.320 13.057.962 4,79% Saham
NORGES BANK $741.431.995 10.976.697 4,05% Saham
Invesco Ltd. $696.520.277 10.380.332 3,80% Saham
Aristotle Capital Management, LLC $614.295.592 9.154.828 3,35% Saham
Zurcher Kantonalbank (Zurich Cantonalbank) $535.795.507 7.915.741 2,93% Saham
FMR LLC $514.221.298 7.662.988 2,81% Saham
UBS Group AG $480.188.202 7.156.307 2,62% Saham
Amundi $445.380.481 6.637.563 2,43% Saham
SIH Partners, LLLP $401.949.130 5.990.300 2,20% Opsi jual
Select Equity Group, L.P. $390.260.022 5.766.342 2,13% Saham
Vontobel Holding Ltd. $381.222.272 5.643.891 2,08% Saham
Pictet Asset Management Holding SA $374.595.529 5.534.203 2,05% Saham
DEUTSCHE BANK AG\ $358.758.941 5.346.631 1,96% Saham
UBS Group AG $338.047.854 5.037.971 1,85% Opsi beli
GOLDMAN SACHS GROUP INC $313.837.596 4.677.162 1,71% Saham
VANGUARD FIDUCIARY TRUST CO $290.970.295 4.315.146 1,59% Saham
Allspring Global Investments Holdings, LLC $274.046.394 4.101.263 1,50% Saham
ROYAL BANK OF CANADA $269.495.000 4.016.341 1,47% Saham
Legal & General Group Plc $258.055.793 3.812.475 1,41% Saham
WGI DM, LLC $232.375.553 3.463.123 1,27% Saham
Southpoint Capital Advisors LP $228.140.000 3.400.000 1,25% Saham
Troy Asset Management Ltd $207.564.521 3.801.548 1,13% Saham
BANK OF AMERICA CORP /DE/ $165.388.819 2.464.811 0,90% Saham
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $160.738.030 2.388.071 0,88% Saham
CAISSE DES DEPOTS ET CONSIGNATIONS $160.694.764 2.374.092 0,88% Saham
JPMORGAN CHASE & CO $150.166.761 2.221.073 0,82% Saham
DIMENSIONAL FUND ADVISORS LP $149.522.514 2.228.302 0,82% Saham
VANGUARD ASSET MANAGEMENT, Ltd $145.859.114 2.163.119 0,80% Saham
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $141.279.713 2.091.787 0,77% Saham
CANADA PENSION PLAN INVESTMENT BOARD $132.275.538 1.958.303 0,72% Saham
Focus Partners Wealth $128.096.242 1.907.874 0,70% Saham
BARCLAYS PLC $125.758.821 1.874.200 0,69% Saham
D. E. Shaw & Co., Inc. $124.655.897 1.857.763 0,68% Saham
CIBC Private Wealth Group LLC $120.584.118 1.618.796 0,66% Saham
Bank Julius Baer & Co. Ltd, Zurich $120.549.426 1.781.615 0,66% Saham
Clearbridge Investments, LLC $113.074.300 1.685.161 0,62% Saham
THORNBURG INVESTMENT MANAGEMENT INC $109.653.266 1.632.356 0,60% Saham
CITIGROUP INC $104.476.376 1.543.514 0,57% Saham
1832 Asset Management L.P. $101.140.031 1.507.303 0,55% Saham
KING LUTHER CAPITAL MANAGEMENT CORP $99.143.873 1.477.554 0,54% Saham
Compagnie Lombard Odier SCmA $92.664.274 1.369.005 0,51% Saham
Liontrust Investment Partners LLP $92.504.035 1.366.637 0,51% Saham
Fiera Capital Corp $92.410.523 1.377.206 0,50% Saham
MORGAN STANLEY $90.174.065 1.343.873 0,49% Saham
PRIMECAP MANAGEMENT CO/CA/ $89.972.108 1.340.866 0,49% Saham
Rudius Management LP $87.761.029 1.307.914 0,48% Saham
Banque Cantonale Vaudoise $78.402.000 1.158.270 0,43% Saham
Allianz Asset Management GmbH $75.013.727 1.108.247 0,41% Saham

Tampilkan semua 705 pemilik institusional →

Aktivis & pemilik 5%+ 1 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju Diajukan Kepemilikan Status Tujuan Pengajuan
Novartis AG ×8 pengajuan 25 Maret 2011 · Pengajuan awal · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Kepemilikan ETF Dimiliki oleh 35 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana Bobot Unit Per tanggal Sumber
EQTY · Valued Advisers Trust 2,98% 616.566 NS 31 Juli 2026 N-PORT
EWL · iShares, Inc. 1,98% 685.049 SH 11 Sep. 2026 Harian
IXJ · iShares Trust 0,42% 262.111 SH 11 Sep. 2026 Harian
ESGD · iShares Trust 0,33% 602.662 SH 11 Sep. 2026 Harian
DMXF · iShares Trust 0,30% 42.350 SH 11 Sep. 2026 Harian
IEV · iShares Trust 0,24% 57.904 SH 11 Sep. 2026 Harian
IEUR · iShares Trust 0,21% 289.698 SH 11 Sep. 2026 Harian
VGK · VANGUARD INTERNATIONAL EQUITY INDEX… 0,21% 1.170.257 SH 19 Agu 2026 Harian
EFV · iShares Trust 0,19% 900.048 SH 11 Sep. 2026 Harian
DFIV · Dimensional ETF Trust 0,16% 488.152 NS 31 Juli 2026 N-PORT
PABD · iShares Trust 0,16% 7.623 SH 11 Sep. 2026 Harian
EFA · iShares Trust 0,15% 1.767.646 SH 11 Sep. 2026 Harian
IMFL · Invesco Exchange-Traded Self-Indexe… 0,15% 25.552 SH 2 Okt. 2026 Harian
INTF · iShares Trust 0,14% 80.343 SH 11 Sep. 2026 Harian
IEFA · iShares Trust 0,13% 3.717.633 SH 11 Sep. 2026 Harian
EFG · iShares Trust 0,11% 274.128 SH 11 Sep. 2026 Harian
IDEV · iShares Trust 0,11% 532.238 SH 11 Sep. 2026 Harian
DFAI · Dimensional ETF Trust 0,10% 262.271 NS 31 Juli 2026 N-PORT
DFIC · Dimensional ETF Trust 0,10% 221.136 NS 31 Juli 2026 N-PORT
VEA · VANGUARD TAX-MANAGED FUNDS 0,10% 4.758.876 SH 19 Agu 2026 Harian
VSGX · VANGUARD WORLD FUND 0,10% 98.214 SH 19 Agu 2026 Harian
PXF · Invesco Exchange-Traded Fund Trust … 0,10% 44.917 SH 2 Okt. 2026 Harian
ACWX · iShares Trust 0,09% 161.852 SH 11 Sep. 2026 Harian
VEU · VANGUARD INTERNATIONAL EQUITY INDEX… 0,08% 1.139.139 SH 19 Agu 2026 Harian
IXUS · iShares Trust 0,08% 679.394 SH 11 Sep. 2026 Harian
VXUS · VANGUARD STAR FUNDS 0,07% 7.162.408 SH 19 Agu 2026 Harian
DXIV · Dimensional ETF Trust 0,07% 2.004 NS 31 Juli 2026 N-PORT
DFAX · Dimensional ETF Trust 0,07% 116.867 NS 31 Juli 2026 N-PORT
DFSI · Dimensional ETF Trust 0,06% 10.784 NS 31 Juli 2026 N-PORT
EFAV · iShares Trust 0,05% 38.852 SH 11 Sep. 2026 Harian
TOK · iShares Trust 0,04% 1.354 SH 11 Sep. 2026 Harian
URTH · iShares, Inc. 0,04% 44.091 SH 11 Sep. 2026 Harian
ACWI · iShares Trust 0,03% 158.434 SH 11 Sep. 2026 Harian
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,03% 419.654 SH 19 Agu 2026 Harian
CRBN · iShares Trust 0,02% 3.453 SH 11 Sep. 2026 Harian

ALC Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21
peringkat · 22 analis BELI
Target median $85.00 +33,3%
4 18,2% Beli Kuat
12 54,5% Beli
4 18,2% Tahan
2 9,1% Jual
0 0,0% Jual Kuat

Target Harga 12 Bulan

15 analis · 2026-09-30

Target rata-rata $84.45 +32,4%

Sekarang Harga saat ini $63.76
Rendah$62.00 Rata-rata$84.45 Tinggi$103.00

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

23

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

Sumber: SEC 20-F diajukan Feb 24, 2026